Spore-forming probiotics for functional dyspepsia - Authors' reply

Affiliations

¹ Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium; Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
² Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium; Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium. Electronic address: tim.vanuytsel@uzleuven.be.

Comment

Lucas Wauters et al. Lancet Gastroenterol Hepatol. 2021 Dec.

. 2021 Dec;6(12):983-984.

doi: 10.1016/S2468-1253(21)00381-2.

¹ Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium; Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
² Department of Gastroenterology and Hepatology, University Hospitals Leuven, 3000 Leuven, Belgium; Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium. Electronic address: tim.vanuytsel@uzleuven.be.

No abstract available

Conflict of interest statement

LW and TV have received speakers’ fees from MY HEALTH.

Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.
Wauters L, Slaets H, De Paepe K, Ceulemans M, Wetzels S, Geboers K, Toth J, Thys W, Dybajlo R, Walgraeve D, Biessen E, Verbeke K, Tack J, Van de Wiele T, Hellings N, Vanuytsel T. Wauters L, et al. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):784-792. doi: 10.1016/S2468-1253(21)00226-0. Epub 2021 Aug 3. Lancet Gastroenterol Hepatol. 2021. PMID: 34358486 Clinical Trial.
Spore-forming probiotics for functional dyspepsia.
Mullie P, Vankrunkelsven P. Mullie P, et al. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):982-983. doi: 10.1016/S2468-1253(21)00340-X. Lancet Gastroenterol Hepatol. 2021. PMID: 34774153 No abstract available.